These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 21533629

  • 1. Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.
    Caletti MG, Missoni M, Vezzani C, Grignoli M, Piantanida JJ, Repetto HA, Exeni R, Rasse SM.
    Pediatr Nephrol; 2011 Aug; 26(8):1247-54. PubMed ID: 21533629
    [Abstract] [Full Text] [Related]

  • 2. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
    Caletti MG, Balestracci A, Missoni M, Vezzani C.
    Pediatr Nephrol; 2013 May; 28(5):745-50. PubMed ID: 23250713
    [Abstract] [Full Text] [Related]

  • 3. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.
    Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876
    [Abstract] [Full Text] [Related]

  • 4. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 5. Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes.
    Cetinkaya R, Odabas AR, Selcuk Y.
    Int J Clin Pract; 2004 May; 58(5):432-5. PubMed ID: 15206496
    [Abstract] [Full Text] [Related]

  • 6. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M, Tylicki L, Rutkowski P, Rutkowski B.
    Scand J Urol Nephrol; 2004 May; 38(5):427-33. PubMed ID: 15764256
    [Abstract] [Full Text] [Related]

  • 7. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 May; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM, Elkayam U, Yellen LG, Krauss D, McKelvie RS, Vaughan DE, Ney DE, Makris L, Chang PI.
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [Abstract] [Full Text] [Related]

  • 9. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 10. ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial.
    Titan SM, M Vieira J, Dominguez WV, Barros RT, Zatz R.
    Clin Nephrol; 2011 Oct; 76(4):273-83. PubMed ID: 21955862
    [Abstract] [Full Text] [Related]

  • 11. Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome.
    Van Dyck M, Proesmans W.
    Pediatr Nephrol; 2004 Jun; 19(6):688-90. PubMed ID: 15064939
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
    Peters H, Border WA, Noble NA.
    Kidney Int; 2000 Apr; 57(4):1493-501. PubMed ID: 10760085
    [Abstract] [Full Text] [Related]

  • 13. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.
    Blezer EL, Nicolay K, Koomans HA, Joles JA.
    Am J Hypertens; 2001 Jan; 14(1):54-61. PubMed ID: 11206680
    [Abstract] [Full Text] [Related]

  • 14. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
    Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, Klein R.
    N Engl J Med; 2009 Jul 02; 361(1):40-51. PubMed ID: 19571282
    [Abstract] [Full Text] [Related]

  • 15. Combined use of enalapril and losartan to reduce proteinuria: a question of safety.
    Ellis D.
    Am J Kidney Dis; 2002 Jan 02; 39(1):209-11. PubMed ID: 11774126
    [No Abstract] [Full Text] [Related]

  • 16. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr 02; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 17. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH.
    Kidney Int; 2000 Feb 02; 57(2):601-6. PubMed ID: 10652037
    [Abstract] [Full Text] [Related]

  • 18. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.
    Ots M, Mackenzie HS, Troy JL, Rennke HG, Brenner BM.
    J Am Soc Nephrol; 1998 Feb 02; 9(2):224-30. PubMed ID: 9527398
    [Abstract] [Full Text] [Related]

  • 19. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
    Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Konno Y, Tsuruga K, Ito E, Waga S.
    Pediatr Int; 2004 Oct 02; 46(5):576-9. PubMed ID: 15491387
    [Abstract] [Full Text] [Related]

  • 20. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
    Azzadin A, Małyszko J, Małyszko JS, Tankiewicz A, Myśliwiec M, Buczko W.
    Pol J Pharmacol; 2002 Oct 02; 54(5):469-73. PubMed ID: 12593533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.